Hyperthyroidism is the most common endocrine disease in older cats, and welfare-centered treatment selection improves quality of life for affected cats and their owners.
Feline hyperthyroidism welfare management requires individualized treatment selection that considers cat temperament, concurrent disease, owner capacity, and long-term welfare goals. The disease itself causes significant distress — elevated metabolic rate, anxiety from hypertension, muscle weakness, and progressive cardiac damage. Treatment selection involves genuine welfare trade-offs: radioactive iodine is curative but requires hospital isolation that is stressful for some cats; daily medication is less stressful to administer but requires compliance. The most important welfare principle is that untreated or inadequately treated hyperthyroidism causes deteriorating quality of life that is preventable with appropriate management. Regular monitoring of thyroid levels, blood pressure, and kidney function allows treatment optimization for each individual cat.